Knockdown of DEPDC1B inhibits the development of glioblastoma

Cancer Cell International
Xu ChenJian Chen

Abstract

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults with a poor prognosis. DEPDC1B (DEP domain-containing protein 1B) has been shown to be associated with some types of malignancies. However, the role and underlying regulatory mechanisms of DEPDC1B in GBM remain elusive. In this research, the expression level of DEPDC1B in GBM tissues was detected by IHC. The DEPDC1B knockdown cell line was constructed, identified by qRT-PCR and western blot and used to construct the xenotransplantation mice model and intracranial xenograft model. MTT assay, colony formation assay, flow cytometry, and Transwell assay were used to detected cell proliferation, apoptosis and migration. The results proved that DEPDC1B was significantly upregulated in tumor tissues, and silencing DEPDC1B could inhibit proliferation, migration and promote apoptosis of GBM cell. In addition, human apoptosis antibody array detection showed that after DEPDC1B knockdown, the expression of apoptosis-related proteins was downregulated, such as IGFBP-2, Survivin, N-cadherin, Vimentin and Snail. Finally, we indicated that knockdown of DEPDC1B significantly inhibited tumor growth in vivo. In summary, DEPDC1B was involved in the development and progre...Continue Reading

References

Jul 6, 2000·Nature Cell Biology·S Sokol
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Oct 15, 2005·The Journal of Clinical Investigation·Francesco NicassioPier Paolo Di Fiore
Sep 23, 2006·Cell·Daniel R BallonJeremy Thorner
Apr 9, 2010·Brain : a Journal of Neurology·Sascha SeidelTill Acker
Jul 12, 2011·Cancer Cell·Javier E GirardiniGiannino Del Sal
May 20, 2014·Journal of Neuro-oncology·Ranjith BabuCory Adamson
May 21, 2014·Neuro-oncology·Quinn T OstromJill S Barnholtz-Sloan
Jun 28, 2014·Biochemical and Biophysical Research Communications·Yi YangMengfeng Li
Aug 1, 2014·The Lancet Oncology·Michael WellerUNKNOWN European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma
Dec 3, 2014·Developmental Cell·Rafael Garcia-Mata
Jun 2, 2015·Expert Review of Neurotherapeutics·Brenda AuffingerMaciej S Lesniak
Aug 25, 2016·Applied Immunohistochemistry & Molecular Morphology : AIMM·Jiaxin ZhaoHuirong Chen
May 31, 2017·Journal of Neuro-oncology·Ryogo KikuchiMasahiro Toda
Jun 25, 2017·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Mohit Kumar JollySukhwinder Singh Sohal
Feb 6, 2018·Cell and Tissue Research·Kaat Durinck, Frank Speleman

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
PCR
transfection
fluorescence
Protein Assay
electrophoresis
xenograft
flow cytometry
antibody array

Software Mentioned

GraphPad Prism
Quantity One
GraphPad

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis